The potential for treating neurodegenerative disorders with NGF-inducing compounds.
Carswell
S
S
Cephalon Inc., West Chester, Pennsylvania 19380.
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000502:physiology / Q000503:physiopathology; D006801:Humans; D007739:L Cells; D051379:Mice; D009414:Nerve Growth Factors / Q000096:biosynthesis*; D009422:Nervous System Diseases / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*
D009414:Nerve Growth Factors